Shanghai Yizhong Pharmaceutical Co., Ltd.

SSE:688091.SS

47.5 (CNY) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q22020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 598.351644.407651.13267.514974.246914.763809.629755.848768.132710.381689.06643.402286.117110.431610.4930.222-50.850.191-123.8560.708
Short Term Investments 13.00903.008460.708305.334325.418315.88324.701323.872338.897346.156319.552665.762832.648341.64123.54101.69940.658247.712123.148
Cash and Short Term Investments 611.36644.407654.138728.2231,279.581,240.1821,125.5091,080.5491,092.0041,049.2781,035.216962.955951.878943.078952.13423.76250.8540.85123.856123.856
Net Receivables 74.66154.451123.995144.298137.599143.192143.011184.66271.70251.38934.60932.37717.7784.1050.03400000
Inventory 49.81345.1730.18130.51130.24428.40625.84215.10415.91217.06115.3419.95516.06911.78110.8861.13101.47701.698
Other Current Assets 36.78532.17937.5039.5196.4351.5161.7511.35181.71281.98324.55710.62936.83924.53633.57514.805014.91905.203
Total Current Assets 772.619776.207845.817912.51,453.8571,413.2441,356.1121,291.6661,261.3291,199.7111,109.7221,037.2481,022.564993.551996.62961.15750.8557.727123.856130.757
Non-Current Assets:
Property, Plant & Equipment, Net 167.777149.279136.564130.678121.399121.651123.205123.079120.626121.452113.83294.03982.77283.94983.96885.627087.815088.037
Goodwill 00000000000000000000
Intangible Assets 8.3088.3628.4168.478.5248.5788.6328.6868.748.7948.8498.9038.9579.0119.0659.11909.22709.389
Goodwill and Intangible Assets 8.3088.3628.4168.478.5248.5788.6328.6868.748.7948.8498.9038.9579.0119.0659.11909.22709.389
Long Term Investments 000473.16021.0091.851.952020.319000105.822105.232104.6420103.48100
Tax Assets 6.247.627.717.0726.295.6454.553.31.9591.8426.4916.4466.2486.07-105.232-104.6420-103.48100
Other Non-Current Assets 511.847506.525489.5753.70525.6473.23321.99622.56525.4252.47590.865103.39296.3992.159105.232104.722265.793104.041-123.85641.43
Total Non-Current Assets 694.172671.786642.265623.085161.861160.116160.234159.582156.75154.883220.037212.779194.375207.011198.265199.468265.793201.083-123.856138.855
Total Assets 1,466.7911,447.9931,488.0821,535.5851,615.7171,573.3591,516.3461,451.2471,418.081,354.5941,329.7591,250.0271,216.941,200.5621,194.894260.625265.793258.810269.613
Liabilities & Equity:
Current Liabilities:
Account Payables 26.94927.69623.49929.65340.24437.69526.62132.13914.09821.53435.3843.3372.4841.1167.41.11802.19801.924
Short Term Debt 0010.90731.01953.144.02820.1000001.8216.75202003.2500
Tax Payables 1.1651.2661.780.66811.7931.2238.40812.35811.6783.5024.0071.9040.2090.3690.4180.2100.29400.401
Deferred Revenue 000.5970.790.9151.11137.1220.7150.3320.1220.2730.201000.4180.2100.29400
Other Current Liabilities 12.65910.48510.1789.176.41621.03817.1038.1516.154.8287.8745.3493.172.8693.9014.46105.76903.089
Total Current Liabilities 40.77339.44646.96171.3112.468103.98484.18752.64931.92629.86447.26610.597.68321.10432.13725.789011.51105.414
Non-Current Liabilities:
Long Term Debt 00000000000000000000
Deferred Revenue Non-Current 0.9211.0291.1371.2441.3551.471.6531.8642.0762.2872.4982.712.9213.1333.3443.55603.79204.419
Deferred Tax Liabilities Non-Current 2.4212.4972.8012.9752.9883.0693.2083.3643.2513.2640.2890.2080.0510.785000000
Other Non-Current Liabilities 00000001.86402.28700000027.791000
Total Non-Current Liabilities 3.3423.5263.9382.9754.3423.0694.865.2285.3265.5512.7872.9182.9723.9183.3443.55627.7913.79204.419
Total Liabilities 44.11542.97250.89874.275116.81107.05389.04857.87737.25235.41550.05313.50810.65625.02235.48129.34527.79115.30409.833
Equity:
Preferred Stock 000000000000026.561000000
Common Stock 206.704206.589205.76205.76158.277158.277158.277158.277143.888143.888105.8105.8105.8105.8105.879.35079.35079.35
Retained Earnings 178.198164.012192.465192.304236.039206.861192.105165.591159.672104.64777.60534.4184.183-26.561-42.688-34.790-22.5640-6.291
Accumulated Other Comprehensive Income/Loss 00065.6611,104.59255.8751,076.91725.6791,077.2671,070.6431,096.30101,096.301-26.5611,096.301-0243.506-0259.7790
Other Total Stockholders Equity 1,037.7751,034.4191,038.9591,062.00201,043.82401,069.50301,070.64301,096.30101,122.8621,096.301186.72-5.504186.720186.72
Total Shareholders Equity 1,422.6761,405.0211,437.1841,460.0661,498.9081,464.8371,427.2991,393.3711,380.8281,319.1781,279.7061,236.5191,206.2841,175.541,159.413231.28238.002243.506259.779259.779
Total Equity 1,422.6761,405.0211,437.1841,460.0661,498.9081,464.8371,427.2991,393.3711,380.8281,319.1781,279.7061,236.5191,206.2841,175.541,159.413231.28238.002243.506259.779259.779
Total Liabilities & Shareholders Equity 1,466.7911,447.9931,488.0821,535.5851,615.7171,573.3591,516.3461,451.2471,418.081,354.5941,329.7591,250.0271,216.941,200.5621,194.894260.625265.793258.81259.779269.613